Home LiteratureArticle Details
PMID: 10522721 Published · ppublish English Journal Article

Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience.

Annals of surgery ·Vol. 230 ·No. 4 ·1999-10-00 ·Pages 512-9; discussion 519-23

Beger HG, Schlosser W, Friess HM, Büchler MW

Abstract

To present preoperative and early postoperative data for 504 patients who underwent duodenum-preserving pancreatic head resection (DPPHR) for severe chronic pancreatitis (CP). The pancreatic head is considered to be the pacemaker of the disease in alcohol-induced CP. Indications for surgery in CP are intractable pain and local complications. DPPHR offers the advantage of treating the complications related to the inflammatory process in the head, relieving the pain syndrome, and preserving the bilioduodenal anatomy, and it may have the potential to change the natural course of chronic pancreatitis. Between November 1972 and December 1998, 504 patients with chronic pancreatitis and an inflammatory mass in the pancreatic head were treated surgically after medical pain treatment for a median of 3.6 years. The procedure resulted in a hospital mortality rate of 0.8%. A continuous follow-up investigation lasting up to 26 years was conducted, during which the patients were reevaluated four times (1983, 1987, 1994, 1996). Between November 1982 and October 1996, 388 patients treated surgically were reinvestigated to evaluate the late outcome; the follow-up rate was 94% (25 patients were lost to follow-up). The reinvestigation evaluation included glucose tolerance test, exocrine pancreatic function test, pain status, physical status, professional and social rehabilitation, and quality of life. After an observation period of up to 14 years, 78.8% of the patients were completely pain-free and 12.5% had (yearly) pain. 91.3% were considered as pain-free; 8.7% had continuing abdominal pain; 12% had abdominal complaints. During the 14 years of follow-up, only 9% were admitted to the hospital for acute episodes of chronic pancreatitis. Endocrine function was improved in 11%; in 21%, diabetes developed de novo. The rate of hospital admission for acute episodes decreased from 69% before surgery to 9% after surgery. In the clinical management period of 9 years (median), the frequency of hospital admission dropped from 5.4 per patient before surgery to 2.7 after surgery. Fourteen years after surgery, 69% of the patients were professionally rehabilitated; in 72%, the quality of life index (Karnofsky criteria) was 90 to 100 and in 18%, it was <80. In patients with alcoholic chronic pancreatitis in whom an inflammatory mass has developed in the pancreatic head, DPPHR results in a change in the natural course of the disease in terms of pain status, frequency of acute episodes, need for further hospital admission, late death, and quality of life.

MeSH Terms
Adult Chronic Disease Duodenum Female Follow-Up Studies Humans Male Pancreatectomy/methods Pancreatitis/surgery Postoperative Period Preoperative Care Time Factors Treatment Outcome
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Beger H G
Department of General Surgery, University of Ulm, Germany.
Schlosser W
Friess H M
Büchler M W
References (44)
44 references, click to expand
  1. Surgical management of chronic relapsing pancreatitis.
    Am J Surg. 1969 Jan;117(1):24-32 PMID: 5782747
  2. Duodenum-preserving pancreatic head resection: Long-term results.
    J Gastrointest Surg. 1997 Jan-Feb;1(1):13-9 PMID: 9834325
  3. Long-term patency, pancreatic function, and pain relief after lateral pancreaticojejunostomy for chronic pancreatitis.
    Gastroenterology. 1980 Aug;79(2):289-93 PMID: 7399232
  4. [Experiences with duodenum-sparing pancreas head resection in chronic pancreatitis].
    Chirurg. 1980 May;51(5):303-7 PMID: 7408575
  5. [Resection of the head of the pancreas (cephalic pancreatectomy) wih conservation of the duodenum in chronic pancreatitis, tumours of the head of the pancreas and compression of the common bile duct (author's transl)].
    Chirurgie. 1981;107(8):597-604 PMID: 7327022
  6. Chronic pancreatitis in Copenhagen. A retrospective study of 64 consecutive patients.
    Scand J Gastroenterol. 1982 Oct;17(7):925-31 PMID: 7156887
  7. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients.
    Gastroenterology. 1984 May;86(5 Pt 1):820-8 PMID: 6706066
  8. Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis.
    Surgery. 1985 Apr;97(4):467-73 PMID: 3983823
  9. Reversibility of exocrine pancreatic failure in chronic pancreatitis.
    Gastroenterology. 1986 Jul;91(1):17-24 PMID: 3486791
  10. Time course and cellular source of pancreatic regeneration following acute pancreatitis in the rat.
    Pancreas. 1986;1(5):421-9 PMID: 2436216
  11. Fluorescein dilaurate serum test: a rapid tubeless pancreatic function test.
    Pancreas. 1987;2(1):53-60 PMID: 3575314
  12. Clinical course and prognosis of chronic pancreatitis.
    Pancreas. 1987;2(4):378-85 PMID: 3628235
  13. Description and rationale of a new operation for chronic pancreatitis.
    Pancreas. 1987;2(6):701-7 PMID: 3438308
  14. Analysis of nerves in chronic pancreatitis.
    Gastroenterology. 1988 Jun;94(6):1459-69 PMID: 3360267
  15. Duodenum-preserving resection of the head of the pancreas in severe chronic pancreatitis. Early and late results.
    Ann Surg. 1989 Mar;209(3):273-8 PMID: 2923514
  16. Pathogenesis and epidemiology of chronic pancreatitis.
    Annu Rev Med. 1989;40:453-68 PMID: 2658760
  17. Inflammatory and immunomodulatory roles of TGF-beta.
    Immunol Today. 1989 Aug;10(8):258-61 PMID: 2478145
  18. Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head.
    World J Surg. 1990 Jan-Feb;14(1):83-7 PMID: 2305590
  19. Changes in peptidergic innervation in chronic pancreatitis.
    Pancreas. 1992;7(2):183-92 PMID: 1372738
  20. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.
    N Engl J Med. 1993 May 20;328(20):1433-7 PMID: 8479461
  21. Progressive loss of pancreatic function in chronic pancreatitis is delayed by main pancreatic duct decompression. A longitudinal prospective analysis of the modified puestow procedure.
    Ann Surg. 1993 May;217(5):458-66; discussion 466-8 PMID: 8489308
  22. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease.
    Digestion. 1993;54(3):148-55 PMID: 8359556
  23. Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis.
    Am J Pathol. 1994 Jan;144(1):117-28 PMID: 7507297
  24. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
    Int J Cancer. 1994 Mar 1;56(5):668-74 PMID: 8314343
  25. Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy.
    Pancreas. 1994 Jan;9(1):47-53 PMID: 8108371
  26. Standards for the diagnosis of chronic pancreatitis and for the evaluation of treatment.
    Int J Pancreatol. 1993 Dec;14(3):205-12 PMID: 8113622
  27. A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene.
    Ann Surg. 1994 Aug;220(2):183-92 PMID: 7519839
  28. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group.
    Am J Gastroenterol. 1994 Sep;89(9):1467-71 PMID: 8079921
  29. Local resection of the head of the pancreas combined with longitudinal pancreaticojejunostomy in the management of patients with chronic pancreatitis.
    Ann Surg. 1994 Oct;220(4):492-504; discussion 504-7 PMID: 7524454
  30. Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma.
    Gut. 1994 Oct;35(10):1468-73 PMID: 7959207
  31. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis.
    Am J Surg. 1995 Jan;169(1):65-9; discussion 69-70 PMID: 7818000
  32. Enhancement of transforming growth factor beta 1 expression in the rat pancreas during regeneration from caerulein-induced pancreatitis.
    Eur J Clin Invest. 1994 Oct;24(10):679-85 PMID: 7851468
  33. [Pancreatic function and quality of life after resection of the head of the pancreas in chronic pancreatitis. A prospective, randomized comparative study after duodenum preserving resection of the head of the pancreas versus Whipple's operation].
    Chirurg. 1995 Apr;66(4):350-9 PMID: 7634946
  34. Estimation of fat absorption with the 13C-trioctanoin breath test after pancreatoduodenectomy or pancreatic head resection.
    World J Surg. 1996 Oct;20(8):1024-8; discussion 1028-9 PMID: 8798360
  35. [Duodenum preserving pancreatic head resection in chronic pancreatitis with inflammatory tumor in the pancreas head].
    Z Gastroenterol. 1996 Nov;34(11):735-41 PMID: 9045535
  36. Pancreatitis and cytokines.
    Acta Gastroenterol Belg. 1996 Jul-Sep;59(3):186-7 PMID: 9015928
  37. [Duodenum preserving resection of the head of the pancrease in therapy of pancreas divisum].
    Chirurg. 1997 Feb;68(2):180-6 PMID: 9156986
  38. Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis.
    Gastroenterology. 1997 May;112(5):1648-55 PMID: 9136844
  39. Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis.
    Gastroenterology. 1997 May;112(5):1656-63 PMID: 9136845
  40. Molecular pattern of ductal pancreatic cancer.
    Langenbecks Arch Surg. 1998 Apr;383(2):105-15 PMID: 9641882
  41. American Gastroenterological Association Medical Position Statement: treatment of pain in chronic pancreatitis.
    Gastroenterology. 1998 Sep;115(3):763-4 PMID: 9721174
  42. AGA technical review: treatment of pain in chronic pancreatitis.
    Gastroenterology. 1998 Sep;115(3):765-76 PMID: 9721175
  43. Role of extracellular matrix in pancreatic diseases.
    Digestion. 1998 Nov-Dec;59(6):625-37 PMID: 9813385
  44. The pancreatic function following subtotal pancreatectomy for cancer.
    Scand J Gastroenterol Suppl. 1971;9:189-93 PMID: 5284144
Article Info
Journal
Annals of surgery
Abbr.
Ann Surg
ISSN
0003-4932
Published
1999-10-00
Pages
512-9; discussion 519-23
Language
English
Region
United States
NLM ID
0372354
PMCID
PMC1420900
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]